The startup has raised $12M in recent months from major investors such as Illumina Ventures, Canaan Partners, and others. The company is founded by Randy Scott (previously involved in founding both Genomic Health and Invitae, which have a combined market cap of $1.3B), Lisa Alderson, and Harvard Medical School geneticist Dr. Robert Green.
In January 2017, Invitae acquired the patient-centered data information company AltaVoice (here). Invitae also has collaborations centered around the Illumina spinout Helix (here) and Invitae announced a new exome service in March 2017 (here). (Illumina has a current market cap of $25B).